Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kaiser

Showing results (391-400 of 410) with videos related to

Pageof 41
Sort By:
Oncoimmunology|November 17, 2022
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cellsNiels Werchau, Bettina Kotter, Elvira Criado-Moronati, et al.
The Journal of Biological Chemistry|October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancerJ Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
EMBO Reports|April 27, 2021
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesTeresa R Wagner, Elena Ostertag, Philipp D Kaiser, et al.
Frontiers in Immunology|January 2, 2024
Two birds with one stone: human SIRPα nanobodies for functional modulation and <i>in vivo</i> imaging of myeloid cellsTeresa R Wagner, Simone Blaess, Inga B Leske, et al.
Nature Communications|May 26, 2021
Immune response to SARS-CoV-2 variants of concern in vaccinated individualsMatthias Becker, Alex Dulovic, Daniel Junker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2006
Evolution of sensory complexity recorded in a myxobacterial genomeB S Goldman, W C Nierman, D Kaiser, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.
Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.
Science Advances|June 25, 2025
PET-based immunomapping of intratumoral CD4<sup>+</sup> cells to monitor acquired resistance to checkpoint inhibitorsStefania Pezzana, Simone Blaess, Bjoern Traenkle, et al.
Pageof 41

Showing results (391-400 of 410) with videos related to

Sort By:
Pageof 41
Oncoimmunology|November 17, 2022
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cellsNiels Werchau, Bettina Kotter, Elvira Criado-Moronati, et al.
The Journal of Biological Chemistry|October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancerJ Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
EMBO Reports|April 27, 2021
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesTeresa R Wagner, Elena Ostertag, Philipp D Kaiser, et al.
Frontiers in Immunology|January 2, 2024
Two birds with one stone: human SIRPα nanobodies for functional modulation and <i>in vivo</i> imaging of myeloid cellsTeresa R Wagner, Simone Blaess, Inga B Leske, et al.
Nature Communications|May 26, 2021
Immune response to SARS-CoV-2 variants of concern in vaccinated individualsMatthias Becker, Alex Dulovic, Daniel Junker, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2006
Evolution of sensory complexity recorded in a myxobacterial genomeB S Goldman, W C Nierman, D Kaiser, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.
Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.
Science Advances|June 25, 2025
PET-based immunomapping of intratumoral CD4<sup>+</sup> cells to monitor acquired resistance to checkpoint inhibitorsStefania Pezzana, Simone Blaess, Bjoern Traenkle, et al.
Pageof 41